Colorescience Finishing Touch Protocol Boosts Patient Satisfaction after Microneedling RF

Colorescience’s Finishing Touch post-treatment skincare protocol improves patient confidence, comfort, satisfaction, and increases the likelihood of a repeat radiofrequency microneedling procedure, according to research in The Journal of Clinical and Aesthetic Dermatology.

(Check out this article on how to incorporate the Colorescience Finishing Touch Protocol.)

Previous publications and clinical studies focused on using the  Colorescience Finishing Touch Protocol after non-ablative and semi-ablative procedures such as IPL (intense pulsed light therapy), chemical peels, fractional resurfacing, traditional microneedling and aesthetic injectable treatments.  Because of the increasing popularity of radiofrequency microneedling among medical aesthetic professionals and patients alike, Colorescience determined it was important to study the efficacy and safety of the protocol when used after this procedure.

 “Based on our results and in-practice experience, the Finishing Touch post-treatment skincare protocol improves patient confidence, comfort, satisfaction, and increases the likelihood of a repeat radiofrequency microneedling procedure,” says Elizabeth Grieshaber, MD a dermatologist at Terezakis & Grieshaber Dermatology in Metairie, LA and lead investigator of the study, in a news release.

Fully 97 percent of subjects observed improvements in redness and/or treatment site marks immediately after application of the skincare protocol. Additionally, 90 percent of subjects reported that they were “very”  or “extremely likely” to have a radiofrequency microneedling procedure again after receiving the Finishing Touch Protocol, and 100 percent said the skincare protocol improved their perception of the radiofrequency microneedling procedure. Side effects reported by four subjects were mild to moderate and were all consistent with the previously reported adverse event profile of microneedling with radio frequency. There were no nodules or granulomas, all events resolved, and the subjects continued with the protocol products.